Impact News +++ Why SelectQuote Stock Soared Today (Fool) +++ SELECTQUOTE Aktie +3,70%

CHUGAI PHARMACEUTICAL ADR Aktie

>CHUGAI PHARMA Performance

1 Woche: +2,4%

1 Monat: -20,6%

3 Monate: -21,4%

6 Monate: -19,9%

1 Jahr: 0%

laufendes Jahr: -14,4%

>CHUGAI PHARMACEUTICAL ADR Aktie

Name:

CHUGAI PHARMACEUTICAL ADR

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US1712691039 / A12ABF

Symbol/ Ticker:

CUP0 (Frankfurt)

Kürzel:

FRA:CUP0, ETR:CUP0, CUP0:GR

Index:

Webseite:

https://www.chugai-pharm...

Profil:

Chugai Pharmaceutical Co., Ltd. is a prominent pla..
>Volltext..

Marktkapitalisierung:

62476.61 Mio. EUR

Unternehmenswert:

56582.1 Mio. EUR

Umsatz:

7123.43 Mio. EUR

EBITDA:

3459.96 Mio. EUR

Nettogewinn:

2354.86 Mio. EUR

Gewinn je Aktie:

1.43 EUR

Schulden:

78.62 Mio. EUR

Liquide Mittel:

2960.14 Mio. EUR

Operativer Cashflow:

2766.69 Mio. EUR

Bargeldquote:

3.83

Umsatzwachstum:

10.29%

Gewinnwachstum:

11.38%

Dividende je Aktie:

0.17 EUR

Dividendenrendite:

2.78%

Dividendenschätzung:

3.82%

Div. Historie:

02.01.25 - 0.17100699€

Insiderhandel:

Suchwörter:

CHUGAI PHARMACEUTICAL ADR, CHUGAI PHARMACEUTICAL, CHUGAI PHARMA, CHUGAI PHARMACEUTICALS

Letzte Datenerhebung:

21.08.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 1645.71 Mio. St.

Frei handelbar: 37.37%

Leerverk. Aktien: -

Rückkaufquote: -

Mitarbeiter: 7778

Umsatz/Mitarb.: 0.82 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 29.43%

Bewertung:

KGV: 26.78

KGV lG: 24.34

KUV: 9

KBV: 5.33

PEG-Ratio: 2.39

EV/EBITDA: 16.35

Rentabilität:

Bruttomarge: 70.37%

Gewinnmarge: 33.06%

Operative Marge: 47.06%

Managementeffizenz:

Gesamtkaprendite: 18.23%

Eigenkaprendite: 21.16%

>Peer Group

Es sind 601 Aktien bekannt.

>CHUGAI PHARMA Chart & Kurs - Frankfurt

>CHUGAI PHARMA News

24.07.25 - 12:09	Chugai Pharmaceutical reports Q2 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.04.25 - 19:45	Chugai Pharmaceutical Co. (CHGCY) Upgraded to Buy: Here′s Why (Zacks)
	Chugai Pharmaceutical Co. (CHGCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

18.04.25 - 05:48	Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai (Japan Times)
	Eli Lilly's orforglipron pill, licensed from Chugai Pharmaceutical, could reshape the booming weight-loss drug market, early data shows....

31.03.25 - 08:42

Mitsubishi Electric Announces Director Candidates (Business Wire)

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that the candidates for Directors, who will be proposed for election at the Ordinary General Meeting of Shareholders scheduled in June 2025, were elected at the company's Nomination Committee meeting held earlier today. 1. Director Candidates (current positions) Tatsuro Kosaka (Director (Senior Advisor, CHUGAI PHARMACEUTICAL CO., LTD.)) Hiroyuki Yanagi (Director (Adviser, Yamaha Motor Co., Ltd.)) Masako Egawa (Director (Chancellor, Seikei Gakuen)) Haruka Matsuyama (Director (Attorney-at-law (Partner, Hibiya Park Law Offices))) Kunihito Minakawa (Director (Financial Services Agency Certified Public Accountants and Auditing Oversight Board Commissioner)) Peter D. Pedersen (Director (Executive Director, NELIS, a corporation engaging in specified non-profit activities)) Kei Uruma (Director; Representative Executive Officer, President & CEO) Atsuhiro Yabu (Director) Noriyuki Takazawa (Senior Vice President; Infrastructure Bu...

30.01.25 - 20:27	Chugai Pharmaceutical GAAP EPS of $253.36, revenue of $1.17B (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.01.25 - 05:30	Research: UBS Lists Asian Stocks w/ 4Q24 Results Expected to Beat Consensus (Table) (AAStocks)
	UBS has listed Asian stocks with results expected to beat market forecasts in 4Q24:Hong Kong StocksCANSINOBIO (06185.HK)SAMSONITE (01910.HK)Stocks Listed in Other RegionsNew Oriental Education & Technology (EDU.US)Chugai Pharmaceutical (4519.T)VNET Group (VNET.US)CATL (300750.SZ)GDS (GDS.US)Zhengzhou Yutong Bus (600066.SH)Bu......

29.07.24 - 23:51	XFRA : NEW INSTRUMENT AVAILABLE - 30.07.2024 - US1712691039 (XETRA)
	Das Instrument CUP0 US1712691039 CHUGAI PHARMAC.UNSP.ADR 2 EQUITY hat seinen ersten Handelstag am 30.07.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N The instrument CUP0 US1712691039 CHUGAI PHARMAC.UNSP.ADR 2 EQUITY has its first trading date on 30.07.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Nur übereilt bestimmt die Neigung sich. - Johann Wolfgang von Goethe

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram